We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biacore Launches Array-Based Protein Interaction Analysis Systems
Product News

Biacore Launches Array-Based Protein Interaction Analysis Systems

Biacore Launches Array-Based Protein Interaction Analysis Systems
Product News

Biacore Launches Array-Based Protein Interaction Analysis Systems


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Biacore Launches Array-Based Protein Interaction Analysis Systems"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biacore International AB has announced the launch of Biacore® A100 and Flexchip systems. Both systems are designed to offer array-based protein interaction analysis.

According to Biacore, high quality data from Biacore systems provides insights into protein interactions for better understanding of biological mechanisms, productivity and reduced development costs.

Biacore has responded to the need for increased throughput in protein interaction analysis by introducing these two array-based systems, both monitoring the entire interaction in real time and without the use of labels.

Flexchip was originally acquired by Biacore earlier this year from HTS Biosystems Inc and is now fully integrated into the Company’s portfolio.

Flexchip is targeted at the explorative research market for simultaneous profiling of a large number of interactions. 

Screening of protein populations enables the mapping of biomolecular networks and the selection of interactions of interest for further analysis.

In contrast, Biacore A100 uses parallel analysis of protein panels against multiple samples to achieve levels of productivity in large-scale functionality studies, compound selection, biotherapeutic development, preclinical and clinical studies.

This system is designed to offer the possibility to obtain and interpret large quantities of quantitative data as demanded for applications in proteomics institutes, pharmaceutical and biotechnology companies.

Erik Walldén, Biacore’s President and CEO commented, “Once again Biacore is at the forefront in real time protein interaction analysis.”

“With these systems we can truly say that Biacore’s products offer a comprehensive approach for applications from pure research, drug discovery to clinical studies and beyond.”

“These systems also allow Biacore to apply its expertise and reinforce its leading position by bringing protein interaction arrays into the rapidly emerging protein array market.”

Advertisement